Sunday, 25 September 2016
Last updated 1 day ago
Jul 31 2009 | 9:46am ET
Alternative investments firm Signal Capital Management has named a biotech expert as executive and academic vice chairman.
Roger van Hanwehr is CEO of energy technology development company Solus and co-founder of consulting firm Arcxeon. He also teaches biotechnology at Georgetown University in Washington, D.C.
Hanwehr, a polymath with expertise in such diverse fields as biological and radiological defense, renewable energy and nanotechnology, will evaluate investment opportunities in his new role at Signal.